Endothelial factors and autoregulation during pressure changes in isolated newborn piglet cerebral arteries. 1998

J Martínez-Orgado, and R González, and M J Alonso, and M A Rodríguez-Martínez, and C F Sánchez-Ferrer, and J Marín
Servicio de Pediatría, Hospital Virgen de la Luz, Cuenca, Spain.

To analyze newborn cerebrovascular autoregulation, middle cerebral arteries from 3-4-d-old piglets were cannulated, and diameter changes after transmural pressure variation were measured. After an equilibration period at 30 mm Hg, pressure was modified from 10 to 70 mm Hg in 20-mm Hg steps. Segments with endothelium showed vasodilation during pressure decrease and vasoconstriction during pressure increase. In each case the maximum response was about 5% that of the resting diameter. Segments without endothelium responded passively to pressure change. Vasodilation during pressure decrease was reduced by the preferential calcium-activated potassium (KCa) channel blocker, tetraethylammonium (1 mM), and was absent with the nitric oxide (NO) synthase inhibitor NG-nitro-L-arginine methylester (L-NAME, 10 microM). The NO synthase substrate, L-arginine (10 microM), counteracted the dilation blockade caused by L-NAME. The cyclooxygenase inhibitor indomethacin (10 microM) and the endothelin A receptor antagonist BQ-123 (10O microM) eliminated the pressure increase-induced vasoconstriction. The ATP-sensitive potassium channel blocker, glibenclamide (1 microM), and the endothelin B receptor antagonist, BQ-788 (10 nM), did not modify the autoregulatory response. None of these drugs modified the passive changes produced by pressure variations in segments without endothelium. These results suggest that: 1) piglet middle cerebral artery autoregulation is endothelium-dependent; 2) NO and KCa channels are involved in vasodilation during transmural pressure decrease, and 3) endothelin-1, through endothelin A receptors, and prostanoids mediate vasoconstriction during pressure increase.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010456 Peptides, Cyclic Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL). Circular Peptide,Cyclic Peptide,Cyclic Peptides,Cyclopeptide,Orbitide,Circular Peptides,Cyclopeptides,Orbitides,Peptide, Circular,Peptide, Cyclic,Peptides, Circular
D010880 Piperidines A family of hexahydropyridines.
D011312 Pressure A type of stress exerted uniformly in all directions. Its measure is the force exerted per unit area. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Pressures
D002536 Cerebral Arteries The arterial blood vessels supplying the CEREBRUM. Arteries, Cerebral,Artery, Cerebral,Cerebral Artery
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005905 Glyburide An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide Glibenclamide,Daonil,Diabeta,Euglucon 5,Euglucon N,Glybenclamide,HB-419,HB-420,Maninil,Micronase,Neogluconin,HB 419,HB 420,HB419,HB420
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation

Related Publications

J Martínez-Orgado, and R González, and M J Alonso, and M A Rodríguez-Martínez, and C F Sánchez-Ferrer, and J Marín
January 2014, Advances in experimental medicine and biology,
J Martínez-Orgado, and R González, and M J Alonso, and M A Rodríguez-Martínez, and C F Sánchez-Ferrer, and J Marín
January 1994, Biology of the neonate,
J Martínez-Orgado, and R González, and M J Alonso, and M A Rodríguez-Martínez, and C F Sánchez-Ferrer, and J Marín
April 1996, Pediatric research,
J Martínez-Orgado, and R González, and M J Alonso, and M A Rodríguez-Martínez, and C F Sánchez-Ferrer, and J Marín
April 1998, Pediatric research,
J Martínez-Orgado, and R González, and M J Alonso, and M A Rodríguez-Martínez, and C F Sánchez-Ferrer, and J Marín
February 2005, Pediatric research,
J Martínez-Orgado, and R González, and M J Alonso, and M A Rodríguez-Martínez, and C F Sánchez-Ferrer, and J Marín
January 1989, Developmental pharmacology and therapeutics,
J Martínez-Orgado, and R González, and M J Alonso, and M A Rodríguez-Martínez, and C F Sánchez-Ferrer, and J Marín
July 1999, The American journal of physiology,
J Martínez-Orgado, and R González, and M J Alonso, and M A Rodríguez-Martínez, and C F Sánchez-Ferrer, and J Marín
September 1958, Acta radiologica,
J Martínez-Orgado, and R González, and M J Alonso, and M A Rodríguez-Martínez, and C F Sánchez-Ferrer, and J Marín
September 1994, General pharmacology,
J Martínez-Orgado, and R González, and M J Alonso, and M A Rodríguez-Martínez, and C F Sánchez-Ferrer, and J Marín
May 2005, The Journal of physiology,
Copied contents to your clipboard!